Jin-Long Chen

Chief Scientific Officer, NGM Biopharmaceuticals (United States).

Companies

Tenaya Therapeutics, Inc.Board member Jul 29, 2021 to Jun 12, 2023¹
NGM Biopharmaceuticals (United States)Board member Apr 3, 2019 to Mar 6, 2023²
NGM Biopharmaceuticals (United States)Chief Scientific Officer Apr 3, 2019 to Mar 6, 2023²

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Mar 2, 2023Granted 64,000 shares of NGM Biopharmaceuticals (United States)³
Jan 17, 2023Sold 85,082 shares at $5.15 of NGM Biopharmaceuticals (United States)⁴
Jan 17, 2023Exercised options 85,082 shares at $1.44 of NGM Biopharmaceuticals (United States)⁴
Dec 7, 2021Sold 15,000 shares at $18.60 of NGM Biopharmaceuticals (United States)⁵
Dec 6, 2021Exercised options 69,444 shares at $1.44 of NGM Biopharmaceuticals (United States)⁵
Dec 6, 2021Sold 15,000 shares at $18.21 of NGM Biopharmaceuticals (United States)⁵
Nov 15, 2021Sold 15,000 shares at $19.56 of NGM Biopharmaceuticals (United States)⁶
Nov 15, 2021Sold 15,000 shares at $19.89 of NGM Biopharmaceuticals (United States)⁶
Oct 12, 2021Sold 15,000 shares at $20.14 of NGM Biopharmaceuticals (United States)⁷
Oct 11, 2021Sold 15,000 shares at $20.41 of NGM Biopharmaceuticals (United States)⁷

The numbers on this page point here. Each one links to the record it came from.